These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 13550834)

  • 1. [Immuno-electrophoretic studies on properdin-zymosan and properdin-inulin complex; an analysis of electrophoretic and immunologic behavior of properdin].
    SCHEIFFARTH F; FRENGER W; GOTZ H
    Klin Wochenschr; 1958 Apr; 36(8):367-9. PubMed ID: 13550834
    [No Abstract]   [Full Text] [Related]  

  • 2. A NEW METHOD FOR THE STUDY OF CYTOTOXIC SYSTEMS (SPECIFIC EVEN NON-SPECIFIC) OF BLOOD SERUMS.
    RYBAK M; PETAKOVA M; SIMONIANOVA E
    Z Immunitats Allergieforsch; 1963 Oct; 125():351-7. PubMed ID: 14117569
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH; Townsend K; Michael AF
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of activation of the properdin system. Studies on properdin electrophoretic mobility in agarose activation of the alternative pathway.
    Adam C; Williams DG; Peters DK
    Clin Exp Immunol; 1975 Nov; 22(2):240-8. PubMed ID: 813932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of highly purified human properdin.
    Ensky J; Hinz CF; Todd EW; Wedgwood RJ; Boyer JT; Lepow IH
    J Immunol; 1968 Jan; 100(1):142-58. PubMed ID: 4169693
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative studies on the properdin-complement system. II. Kinetics of the reaction between properdin and zymosan.
    LEON MA
    J Exp Med; 1957 May; 105(5):403-15. PubMed ID: 13428911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The properdin system and immunity. III. The zymosan assay of properdin.
    PILLEMER L; BLUM L; LEPOW IH; WURZ L; TODD EW
    J Exp Med; 1956 Jan; 103(1):1-13. PubMed ID: 13278451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative studies on the properdin-complement system.
    LEON MA
    J Exp Med; 1956 Mar; 103(3):285-93. PubMed ID: 13295486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research on the properdin system. I. Inactivation of the third complement component through zymosan on inulin.
    HEISE ER
    Klin Wochenschr; 1958 Jan; 36(2):88-9. PubMed ID: 13540126
    [No Abstract]   [Full Text] [Related]  

  • 10. The possible role of the properdin system in transplantable cancer; the effect of zymosan on transplantable human carcinoma.
    HERBUT PA; KRAEMER WH
    Cancer Res; 1956 Dec; 16(11):1048-52. PubMed ID: 13383472
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of the alternate pathway in chelated serum.
    Forsgren A; Mclean RH; Michael AF; Quie PG
    J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the immunochemical properties of highly purified properdin in human serum.
    Minta JO
    J Immunol; 1975 Apr; 114(4):1415-21. PubMed ID: 123262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Purification and study of some physicochemical properties of the specific serum protein of cancer patients].
    Goncharenko EG
    Ukr Biokhim Zh; 1966; 38(4):371-7. PubMed ID: 4174086
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.
    Schreiber RD; Götze O; Müller-Eberhard HJ
    J Exp Med; 1976 Oct; 144(4):1062-75. PubMed ID: 62010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunofixation. I. General principles and application to agarose gel electrophoresis.
    Ritchie RF; Smith R
    Clin Chem; 1976 Apr; 22(4):497-9. PubMed ID: 56244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple method for isolation of human properdin by affinity chromatography.
    Konno T; Hirai H
    J Immunol Methods; 1976; 12(1-2):47-55. PubMed ID: 792350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
    Stitzel AE; Spitzer RE
    J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides.
    LANDY M; PILLEMER L
    J Exp Med; 1956 Jun; 103(6):823-33. PubMed ID: 13319594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enrichment and immunologic determination of properdin in serum].
    Tympner KD; Strauch L
    Monatsschr Kinderheilkd (1902); 1968 Jun; 116(6):394-7. PubMed ID: 5718330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the bactericidal action of normal serum and the properdin system. II. With special reference to immuno-electrophoretic analysis].
    YAMAGUCHI Y; TOSHIOKA T; NACHI I; NUMATA T
    Nihon Saikingaku Zasshi; 1962 Jan; 17():8-13. PubMed ID: 14008806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.